//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...





Loading...
(5/5) Why it matters: In vivo ablation of NVP-associated programs remodels the tumor and significantly extends survival. These studies move us from descriptive atlases to a mechanistic, targetable understanding of tumor organization. Check them out!
(4/5) Next: Meet the NVP (Neurovascular Progenitor) 🧬. This rare population co-expresses neural and perivascular programs. Using patient-derived lineage tracing, we proved NVPs can bridge the gap, giving rise to both neural and mesenchymal fates.
(1/5) How does glioblastoma maintain its immense heterogeneity? 🧠 Two new companion papers from the Bhaduri Lab @UCLA now on @bioRxiv offer a lineage-resolved view of GBM hierarchies. Let’s dive in! 🧵👇 www.biorxiv.org/content/10.6... www.biorxiv.org/content/10.1...
(3/5) These relationships organize into reproducible "Tracks". By understanding these clonal architectures, we can design "hierarchy-informed" combination to disrupt the interactions that drive tumor growth.
(2/5) First up: CellTagging! We integrated DNA barcoding with scRNA-seq in 235k+ cells from 9 patient tumors. We found that GBM growth is sustained by multiple non-redundant progenitors, not just one dominant stem cell. #GBM #CancerResearch
3mo
🌡️ HOTT isn't just about temperature. Human Organoid Tumor Transplantation (HOTT) is one of the models Dr. Bhaduri's lab (@bhadurilab.bsky.social) developed to understand how interactions with #glioblastoma tissue and immune cells contribute to therapy failure. #Neuroskyence @dgsomucla.bsky.social
3mo
3mo
3mo
3mo
4mo